Research advances in the diagnosis and prognosis of 5α-reductase type 2 deficiency

References:

[1] Gui BH,Song YN,Su Z,et al.New insights into 5α-reductase type 2 deficiency based on a multi-centre study:regional distribution and genotype-phenotype profiling of SRD5A2 in 190 Chinese patients[J].J Med Genet,2019,56(10):685-692.DOI:10.1136/jmedgenet-2018-105915.
[2] Cheon CK.Practical approach to steroid 5alpha-reductase type 2 deficiency[J].Eur J Pediatr,2011,170(1):1-8.DOI:10.1007/s00431-010-1189-4.
[3] Guerra-Júnior G,Maciel-Guerra AT.The role of the pediatrician in the management of children with genital ambiguities[J].J Pediatr,2007,83(5 Suppl):184-191.DOI:10.2223/jped.1706.
[4] Costa EMF,Domenice S,SirciliM H,et al.DSD due to 5α-reductase 2 deficiency-from diagnosis to long term outcome[J].Semin Reprod Med,2012,30(5):427-431.DOI:10.1055/s-0032-1324727.
[5] Avenda OA,Paradisi I,Cammarata-Scalisi F,et al.5-α-Reductase type 2 deficiency:is there a genotype-phenotype correlation?A review[J].Hormones,2018,17(4):1-8.DOI:10.1007/s42000-018-0013-9.
[6] Di W,Hui C,Gong CX.Physical assessment and reference growth curves for children with 46,XY disorders of sex development[J].Pediatr Investig,2017,12(1):16-22.DOI:10.1002/ped4.12010.
[7] Zhao X,Song YN,Chen SK,et al.Growth pattern in Chinese children with 5α-reductase type 2 deficiency:a retrospective multicenter study[J].Front Pharmacol,2019,10:173-182.DOI:10.3389/fphar.2019.00173.
[8] Khorashad BS,Roshan GM,Reid AG,et al.Childhood sex-typed behavior and gender change in individuals with 46,XY and 46,XX Disorders of sex development:an Iranian multicenter study[J].Arch Sex Behav,2018,47(8):2287-2298.DOI:10.1007/s10508-018-1281-9.
[9] Mendonca BB,Batista RL,Domenice S,et al.Steroid 5α-reductase 2 deficiency[J].J Steroid Biochem Mol Biol,2016,163:206-211.DOI:10.1016/j.jsbmb.2016.05.020.
[10] Richardson EJ,Scott FP,McLennan AC.Sex discordance identification following non-invasive prenatal testing[J].Prenat Diagn,2019,4(4):339-349.DOI:10.1002/pd.5184.
[11] Zelig CM,Knutzen DM,Ennen CS,et al.Chorionic villus sampling,early amniocentesis,and termination of pregnancy without diagnostic testing:comparison of fetal risk following positive non-invasive prenatal testing[J].J Obstet Gynaecol Can,2016,38(5):441-445.e2.DOI:10.1016/j.jogc.2016.03.006.
[12] Wisniewski AB,Batista RL,Costa EMF,et al.Management of 46,XY differences/disorders of sex development (DSD) throughout life[J].Endocr Rev,2019,40(6):1547-1572.DOI:10.1210/er.2019-00049.
[13] Shiraishi S,Lee PWN,Leung A,et al.Simultaneous measurement of serum testosterone and dihydrotestosterone by liquid chromatography-tandem mass spectrometry[J].Clin Chem,2008,54(11):1855-1863.DOI:10.1373/clinchem.2008.103846.
[14] Abac? A,?atl? G,K?rb?y?k?,et al.Genotype-phenotype correlation,gonadal malignancy risk,gender preference,and testosterone/dihydrotestosterone ratio in steroid 5-alpha-reductase type 2 deficiency:a multicenter study from Turkey[J].J Endocrinol Invest,2019,42(4):453-470.DOI:10.1007/s40618-018-0940-y.
[15] Berra M,Williams EL,Muroni B,et al.Recognition of 5α-reductase-2 deficiency in an adult female 46XY DSD clinic[J].Eur J Endocrinol,2011,164(6):1019-1025.DOI:10.1530/eje-10-0930]
[16] Chan AOK,But BWM,Lee CY,et al.Diagnosis of 5α-reductase 2 deficiency:is measurement of dihydrotestosterone essential?[J].Clin Chem,2013,59(5):798-806.DOI:10.1373/clinchem.2012.196501.
[17] Walter KN,Kienzle FB,Frankenschmidt A,et al.Difficulties in diagnosis and treatment of 5alpha-reductase type 2 deficiency in a newborn with 46,XY DSD[J].Horm Res Paediatr,2010,74(1):67-71.DOI:10.1159/000313372.
[18] Cools M,Nordenstr m A,Robeva R,et al.Caring for individuals with a difference of sex development (DSD):a Consensus Statement[J].Nat Rev Endocrinol,2018,14(7):415-429.DOI:10.1038/s41574-018-0010-8.
[19] 陈艳,李瑞珍,王曦.5α-还原酶2型缺乏症的临床研究热点[J].国际儿科学杂志,2018,45(11):860-864.DOI:10.3760/cma.j.issn.1673-4408.2018.11.011. Chen Y,Li RZ,Wang X,et al.Hotspots of clinical trials on 5α-reductase 2 deficiency[J].Int J Pediatr,2018,45(11):860-864.DOI:10.3760/cma.j.issn.1673-4408.2018.11.011.
[20] Batista RL,Inácio M,Arnhold IJP,et al.Psychosexual aspects,effects of prenatal androgen exposure,and gender change in 46,XY disorders of sex development[J].J Clin Endocrinol Metab,2019,104(4):1160-1170.DOI:10.1210/jc.2018-01866.
[21] Mouriquand PDE,Gorduza DB,Gay CL,et al.Surgery in disorders of sex development (DSD) with a gender issue:If (why),when,and how?[J].J Pediatr Urol,2016,12(3):139-149.DOI:10.1016/j.jpurol.2016.04.001.
[22] 毛宇,夏梦,蔡永川,等.46,XY严重男性化不全外阴的男性化整形方式探讨[J].临床小儿外科杂志,2019,18(3):196-201.DOI:10.3969/j.issn.1671-6353.2019.03.007. Mao Y,Xia M,Cai YC,et al.Masculinizing plasty in 46,XY severely undervirilized genital[J].J Clin Ped Sur,2019,18(3):196-201.DOI:10.3969/j.issn.1671-6353.2019.03.007.
[23] Sircili MH,e Silva FA,Costa EM,et al.Long-term surgical outcome of masculinizing genitoplasty in large cohort of patients with disorders of sex development[J].J Urol,2010,184(3):1122-1127.DOI:10.1016/j.juro.2010.05.022.
[24] Babu R,Chakravarthi S.The role of preoperative intra muscular testosterone in improving functional and cosmetic outcomes following hypospadias repair:A prospective randomized study[J].J Pediatr Urol,2018,14(1):29.e21-e26.DOI:10.1016/j.jpurol.2017.07.009.
[25] Surampudi P,Swerdloff RS,Wang C.An update on male hypogonadism therapy[J].Expert Opin Pharmacother,2014,15(9):1247-1264.DOI:10.1517/14656566.2014.913022.
[26] Xu D,Lu LS,Xi L,et al.Efficacy and safety of percutaneous administration of dihydrotestosterone in children of different genetic backgrounds with micropenis[J].J Pediatr Endocrinol Metab,2017,30(12):1285-1291.DOI:10.1515/jpem-2016-0400.
[27] 王朝旭,宋宏程,张潍平,等.性别发育异常合并重度尿道下裂尿道成形术术式探讨[J].中华小儿外科杂志2019,40(4):337-340.DOI:10.3760/cma.j.issn.0253-3006.2019.04.011. Wang CX,Song HC,Zhang WP,et al.Efficacy of urethroplasty for disorders of sex development with concurrent severe hypospadias[J].Chin J Pediatr Surg,2019,40(4):337-340.DOI:10.3760/cma.j.issn.0253-3006.2019.04.011.
[28] Mendonca BB,Costa EMF,Belgorosky A,et al.46,XY DSD due to impaired androgen production[J].Best Pract Res Clin Endocrinol Metab,2010,24(2):243-262.DOI:10.1016/j.beem.2009.11.003.
[29] Khorashad BS,Aghili Z,Kreukels BPC,et al.Mental health and disorders of sex development/intersex conditions in Iranian culture:congenital adrenal hyperplasia,5-α reductase deficiency-type 2,and complete androgen insensitivity syndrome[J].Arch Sex Behav,2018,47(4):931-942.DOI:10.1007/s10508-017-1139-6.
[30] Godfrey LM.Mental health outcomes among individuals with 46,XY disorders of sex development:A systematic review[J].J Health Psychol,2020:1359105320909863.DOI:10.1177/1359105320909863.
[31] Hadziselimovic F,Dessouky N.Differences in testicular development between 5alpha-reductase 2 deficiency and isolated bilateral cryptorchidism[J].J Urol,2008,180(3):1116-1120.DOI:10.1016/j.juro.2008.05.063.
[32] Kang HJ,Imperato-McGinley J,Zhu YS,et al.The first successful paternity through in vitro fertilization-intracytoplasmic sperm injection with a man homozygous for the 5α-reductase-2 gene mutation[J].Fertil Steril,2011,95(6):2125-2128.DOI:10.1016/j.fertnstert.2011.01.121.